Form 8-K - Current report:
SEC Accession No. 0001213900-26-067711
Filing Date
2026-06-11
Accepted
2026-06-11 12:43:58
Documents
51
Period of Report
2026-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0294448-8k_adial.htm   iXBRL 8-K 130605
2 AGREEMENT AND PLAN OF MERGER, DATED JUNE 11, BY AND AMONG ADIAL PHARMACEUTICALS, ea029444801ex2-1.htm EX-2.1 889274
3 CERTIFICATE OF DESIGNATION OF SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK, D ea029444801ex3-1.htm EX-3.1 103835
4 FORM OF PRE-FUNDED WARRANT (FINANCING) ea029444801ex4-1.htm EX-4.1 93024
5 FORM OF WARRANT (FINANCING) ea029444801ex4-2.htm EX-4.2 93276
6 FORM OF PRE-FUNDED WARRANT (NOTE EXCHANGE) ea029444801ex4-3.htm EX-4.3 93023
7 FORM OF WARRANT (NOTE EXCHANGE) ea029444801ex4-4.htm EX-4.4 93358
8 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 11, 2026, BY AND AMONG A ea029444801ex10-1.htm EX-10.1 263468
9 FORM OF EXCHANGE AGREEMENT, DATED AS OF JUNE 11, 2026, BY AND AMONG ADIAL PHARMA ea029444801ex10-2.htm EX-10.2 243405
10 FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG ADIAL PHARMACEUTICALS, INC. ea029444801ex10-3.htm EX-10.3 150190
11 AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTI ea029444801ex10-4.htm EX-10.4 17767
12 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND TONY G ea029444801ex10-5.htm EX-10.5 18064
13 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND VINAY ea029444801ex10-6.htm EX-10.6 18197
14 PRESS RELEASE ISSUED ON JUNE 11, 2026 ea029444801ex99-1.htm EX-99.1 25402
15 INVESTOR PRESENTATION, DATED JUNE 2026 ea029444801ex99-2.htm EX-99.2 41566
16 GRAPHIC ea029444801_ex99-2img1.jpg GRAPHIC 550615
17 GRAPHIC ea029444801_ex99-2img2.jpg GRAPHIC 807284
18 GRAPHIC ea029444801_ex99-2img3.jpg GRAPHIC 503937
19 GRAPHIC ea029444801_ex99-2img4.jpg GRAPHIC 491138
20 GRAPHIC ea029444801_ex99-2img5.jpg GRAPHIC 420914
21 GRAPHIC ea029444801_ex99-2img6.jpg GRAPHIC 615901
22 GRAPHIC ea029444801_ex99-2img7.jpg GRAPHIC 619524
23 GRAPHIC ea029444801_ex99-2img8.jpg GRAPHIC 441173
24 GRAPHIC ea029444801_ex99-2img9.jpg GRAPHIC 523766
25 GRAPHIC ea029444801_ex99-2img10.jpg GRAPHIC 769371
26 GRAPHIC ea029444801_ex99-2img11.jpg GRAPHIC 502291
27 GRAPHIC ea029444801_ex99-2img12.jpg GRAPHIC 426108
28 GRAPHIC ea029444801_ex99-2img13.jpg GRAPHIC 546043
29 GRAPHIC ea029444801_ex99-2img14.jpg GRAPHIC 538943
30 GRAPHIC ea029444801_ex99-2img15.jpg GRAPHIC 344129
31 GRAPHIC ea029444801_ex99-2img16.jpg GRAPHIC 787427
32 GRAPHIC ea029444801_ex99-2img17.jpg GRAPHIC 418940
33 GRAPHIC ea029444801_ex99-2img18.jpg GRAPHIC 385320
34 GRAPHIC ea029444801_ex99-2img19.jpg GRAPHIC 597292
35 GRAPHIC ea029444801_ex99-2img20.jpg GRAPHIC 590326
36 GRAPHIC ea029444801_ex99-2img21.jpg GRAPHIC 382373
37 GRAPHIC ea029444801_ex99-2img22.jpg GRAPHIC 491135
38 GRAPHIC ea029444801_ex99-2img23.jpg GRAPHIC 452482
39 GRAPHIC ea029444801_ex99-2img24.jpg GRAPHIC 376550
40 GRAPHIC ea029444801_ex99-2img25.jpg GRAPHIC 341567
41 GRAPHIC ea029444801_ex99-2img26.jpg GRAPHIC 472751
  Complete submission text file 0001213900-26-067711.txt   21465965

Data Files

Seq Description Document Type Size
42 XBRL SCHEMA FILE adil-20260611.xsd EX-101.SCH 3005
43 XBRL LABEL FILE adil-20260611_lab.xml EX-101.LAB 34239
44 XBRL PRESENTATION FILE adil-20260611_pre.xml EX-101.PRE 22352
54 EXTRACTED XBRL INSTANCE DOCUMENT ea0294448-8k_adial_htm.xml XML 3306
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 261082315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)